Earnings and Equity Valuation in the Biotech Industry : Theory and Evidence
Year of publication: |
[2012]
|
---|---|
Authors: | Joos, Philip |
Other Persons: | Zhdanov, Alexei (contributor) |
Publisher: |
[2012]: [S.l.] : SSRN |
Extent: | 1 Online-Ressource (45 p) |
---|---|
Type of publication: | Book / Working Paper |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments May 20, 2007 erstellt |
Other identifiers: | 10.2139/ssrn.987924 [DOI] |
Classification: | G12 - Asset Pricing ; G31 - Capital Budgeting; Investment Policy ; M41 - Accounting |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Understanding the Accrual Anomaly
Zhang, Lu, (2007)
-
Potential dividends versus actual cash flows in firm valuation
Magni, Carlo Alberto, (2009)
-
Risky Tax Shields and Risky Debt: A Monte Carlo Approach
Pareja, Ignacio Velez, (2010)
- More ...
-
Earnings and Equity Valuation in the Biotech Industry: Theory and Evidence
Joos, Philip, (2008)
-
Earnings and equity valuation in the biotech industry : theory and evidence
Joos, Philip, (2008)
-
Earnings and Equity Valuation in the Biotech Industry: Theory and Evidence
Joos, Philip, (2008)
- More ...